Momenta pharmaceuticals, inc. (MNTA)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net Income (Loss) Available to Common Stockholders, Basic

-39,555

-86,700

-44,543

-113,969

-44,843

-8,245

-50,300

-69,885

-47,631

13,759

-33,188

-36,908

-31,759

41,539

-17,544

-20,986

-24,012

-29,164

-30,050

-2,222

-21,877

-15,981

-29,101

-26,156

-27,362

-30,061

-25,382

-28,849

-24,116

-17,677

-25,822

-10,167

-4,982

-1,253

60,338

64,265

57,006

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization of property and equipment

735

753

825

4,173

5,859

4,342

1,886

1,903

1,786

3,304

1,673

1,780

1,266

1,874

1,922

1,915

1,889

1,795

1,836

1,874

2,089

1,974

2,026

1,774

1,863

2,563

954

1,809

1,782

1,828

1,753

1,563

1,275

-112

1,948

1,184

1,117

Share-based compensation expense

4,823

8,605

6,689

3,662

3,474

1,050

10,126

5,172

4,874

-182

4,916

4,590

6,803

3,566

4,939

4,989

4,828

4,653

4,556

6,616

-4,385

3,079

3,399

3,665

3,451

3,466

3,155

3,330

2,871

3,452

3,549

3,457

3,254

3,122

3,117

3,133

1,766

Amortization of premium on investments

21

194

388

565

581

263

253

-4

-74

81

-137

-74

-37

-71

-95

-139

-290

-396

-424

-259

-304

-307

-406

-602

-847

-948

-884

-894

-849

-1,111

-966

-698

-513

-463

-506

-463

-245

Amortization of intangibles

289

288

288

289

288

288

288

289

288

288

289

288

288

289

342

633

265

265

266

265

265

265

266

265

265

265

266

265

265

265

265

266

265

-

-

-

75

Gain on disposal of assets

13

-39

374

-25

440

113

13

-560

-76

-61

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

0

0

-3

-

-

-

-

Changes in operating assets and liabilities:
Collaboration receivable

8,579

2,343

1,272

1,412

-8,385

-2,464

606

8,476

-10,295

715

-10,473

-1,738

-43,698

-

-

14,120

557

8,156

-23,098

24,126

1,665

-726

-919

764

-5,291

6,693

3,303

-2,297

-5,415

5,860

-14,401

-3,020

-5,799

-56,568

-64

2,449

27,869

Unbilled revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

521

-1,210

332

-1,932

3,877

236

432

-384

130

-59

-1,652

214

-184

807

-3,337

Prepaid expenses and other current assets

1,060

920

2,639

-840

1,508

1,000

740

-2,108

-205

364

-486

1,714

506

-

-

-320

926

150

798

-777

-157

-236

1,167

-1,066

199

-1,250

310

702

-1,314

1,389

730

-238

525

-463

362

472

383

Other long-term assets

-1,476

-1,376

2,336

-2,463

-2,722

765

-47

35

-50

-158

-164

-844

-63

-

-

-42

730

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-11,724

10,681

-6,540

680

10

4,735

-3,076

2,818

-5,635

-635

-907

5,550

3,438

-

-

8,751

-665

-1,666

3,824

-3,599

-1,939

4,283

-835

-869

-1,453

113

3,443

-892

63

-3,141

2,879

-5,579

4,712

2,154

-676

-1,497

334

Accrued expenses

-8,115

31,653

10,930

4,792

-3,962

-4,054

2,483

-912

-3,746

-2,871

-6,488

7,059

-3,953

-

-

-543

-8,268

10,372

-3,218

10,034

-3,037

-1,560

699

1,185

-1,423

-327

2,220

2,255

-2,342

1,692

-2,801

3,916

-2,297

-837

2,966

1,315

-3,411

Accrued restructuring

0

-223

-854

-445

-1,679

-5,439

8,674

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration liabilities

-2,157

-160

11

1,502

-1,951

1,535

-2,771

-1,931

-1,370

-4,630

-6,471

-6,844

-5,692

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-192

-287

-721

-1,506

-1,341

-31,542

-631

-517

-748

-50,715

-1,123

-1,382

48,205

-

-

-4,286

41,636

-2,443

-2,442

-2,443

-1,687

6,070

-887

-860

-1,041

-982

-948

-1,026

-1,023

-1,260

-1,335

-1,364

31,890

-542

-541

-536

-530

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

6

17

Lease incentive

-

-

-

-

-

-

-

-

-

3,389

662

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-522

-14,420

-927

25,801

-2,025

-7,091

-13,113

32,057

3,329

-1,604

188

1,361

-11

-

-

12

-350

-83

-36

41

20

-

-

-

-19

266

-60

-82

-142

314

-45

11

202

-

-

-

-

Other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

1,167

-

-

372

523

-60

-121

-150

-151

-150

-115

-99

-97

416

-6

-55

-55

661

-11

-69

-64

-

-

-

-

Net cash used in operating activities

-64,615

-37,969

-55,571

-73,670

-37,592

-34,198

-46,394

-36,845

-38,153

-38,209

-29,189

-24,731

63,044

45,144

-27,316

-22,762

13,923

-24,333

-2,602

-16,004

-28,576

-1,082

-24,915

-18,962

-20,209

-26,821

-23,712

-20,748

-15,551

-19,215

-7,061

-6,422

41,697

48,180

69,357

64,518

31,670

Cash Flows from Investing Activities:
Purchases of property and equipment

857

39

680

920

137

425

1,883

3,156

3,555

5,914

5,494

4,019

1,700

803

1,102

2,164

1,540

1,321

1,387

821

539

2,453

1,189

2,215

2,503

2,890

2,966

2,792

802

878

2,750

3,660

8,203

2,919

1,538

1,763

2,479

Proceeds from disposal of equipment

16

156

543

1,164

1,285

1,363

13

59

12

267

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of marketable securities

198,054

32,563

47,491

60,612

133,915

85,085

47,658

26,348

43,434

158,596

96,900

222,008

47,384

95,103

42,923

102,614

119,368

124,173

213,460

52,346

15,694

43,004

4,521

29,919

34,365

51,807

25,795

43,550

108,817

80,684

115,761

129,281

189,362

127,628

132,497

153,831

137,316

Proceeds from maturities of marketable securities

52,073

73,728

64,656

126,100

50,690

100,719

70,457

45,620

91,382

102,491

192,558

49,188

76,432

95,134

88,805

127,329

134,397

140,063

13,510

47,842

44,492

34,062

21,865

68,435

70,980

73,614

59,889

49,902

110,778

68,821

142,043

168,163

144,545

65,535

116,698

54,450

65,732

Proceeds from sales of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,822

-

-

-

-

-

-

-

-

Net cash used in investing activities

-146,822

41,282

17,028

65,732

-82,077

16,572

20,929

16,175

44,405

-61,752

90,164

-176,839

27,348

-772

44,780

22,551

13,489

14,569

-201,337

-5,325

28,259

-11,395

16,155

36,301

34,112

18,917

31,128

3,560

4,981

-12,741

23,132

35,222

-53,020

-69,512

-24,001

-101,144

-74,063

Cash Flows from Financing Activities:
Payment of financing fees related to public offering

257

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash Flows from Financing Activities:
Net proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

0

0

49,649

14,441

0

0

0

0

0

0

30,838

33,665

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock under stock plans

8,869

12,591

1,117

218

2,563

1,521

6,979

12,449

8,323

774

2,293

2,275

4,916

1,189

591

69

558

1,238

2,119

18,299

2,911

645

717

70

1,841

539

3,201

414

868

49

499

870

735

657

1,362

2,749

778

Net cash provided by financing activities

8,612

257,071

1,117

218

2,563

219,307

6,979

12,449

8,323

774

2,293

51,924

19,357

1,188

591

-996

558

1,238

2,119

195,528

36,576

18,950

717

70

1,841

539

3,201

414

868

49

499

870

735

106

1,263

1,820

370

Payments on financed leasehold improvements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

65

193

Principal payments on capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

551

99

864

215

Net decrease in cash, cash equivalents and restricted cash

-202,825

260,384

-37,426

-7,720

-117,106

201,681

-18,486

-8,221

14,575

-99,187

63,268

-149,646

109,749

45,560

18,055

-1,207

27,970

-8,526

-201,820

174,199

36,259

6,473

-8,043

17,409

15,744

-7,365

10,617

-16,774

-9,702

-31,907

16,570

29,670

-10,588

-21,226

46,619

-34,806

-42,023

Non-Cash Activities:
Purchases of property and equipment included in accounts payable and accrued expenses

677

659

-137

251

278

-1,185

365

-365

1,228

-2,314

2,222

269

1,051

668

-238

505

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing fees in accounts payable

7

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receivable due from broker for issuance of common stock under ATM facility

-

-

-

-

-

-

-

-

-

-

-

-

4,072

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receivable due from stock option exercises

0

-

-

-

14

-

-

-

643

-524

-420

1,075

-38

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impact of adopting ASU 2016-09

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

14

34

41

Accounting Standards Update 2014-09
Impact from adoption of ASUs

-

-

-

-

-

0

0

0

5,511

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-